Search

Bud Tennant Phones & Addresses

  • 4 Sunny Knoll Rd, Ithaca, NY 14850 (607) 273-2405
  • Bethesda, MD

Work

Position: Educator

Education

Degree: Graduate or professional degree

Emails

Resumes

Resumes

Bud Tennant Photo 1

James Law Professor Of Comparative Medicine At Cornell University

View page
Position:
James Law Professor of Comparative Medicine at Cornell University
Location:
Ithaca, New York Area
Industry:
Higher Education
Work:
Cornell University
James Law Professor of Comparative Medicine
Bud Tennant Photo 2

James Law Professor Of Comparative Medicine

View page
Location:
4 Sunny Knoll Rd, Ithaca, NY 14850
Industry:
Higher Education
Work:
Cornell University
James Law Professor of Comparative Medicine

Business Records

Name / Title
Company / Classification
Phones & Addresses
Bud C. Tennant
Vice-President
MARMOTECH, INC
Breed Woodchucks to Be Used for Hepatitis Research
4 Sunny Knl, Ithaca, NY 14850
(607) 275-9710
Bud C. Tennant
Professor
Bud Tennant
Consultant
4 Sunny Knl Rd, Ithaca, NY 14850

Publications

Us Patents

Animal Model For Flaviviridae Infection

View page
US Patent:
6878364, Apr 12, 2005
Filed:
Dec 3, 2001
Appl. No.:
10/006524
Inventors:
Edward J. Dubovi - Ithaca NY, US
Bud C. Tennant - Ithaca NY, US
James R. Jacob - Cortland NY, US
Assignee:
Cornell Research Foundation, Inc. - Ithaca NY
International Classification:
C11Q001/18
C12N005/06
A61K049/00
C12Q001/70
US Classification:
424 92, 435325, 435 5, 435 32
Abstract:
The present invention is a woodchuck or an isolated woodchuck cell infected with bovine viral diarrhea virus. The invention can be used to identify new compounds for the treatment of flavivirus, pestivirus or hepatitis C infection using these models.

Method Of Treating Hepatitis Delta Virus Infection

View page
US Patent:
7511027, Mar 31, 2009
Filed:
Nov 22, 2002
Appl. No.:
10/302814
Inventors:
John L. Casey - Potomac MD, US
Brent E. Korba - Laurel MD, US
Paul J. Cote - New Market MD, US
John L. Gerin - Bethesda MD, US
Bud C. Tennant - Ithaca NY, US
Chung K. Chu - Athens GA, US
Assignee:
Georgetown University - Ithaca NY
University of Georgia Research Foundation, Inc. - Atlanta GA
International Classification:
A61K 45/00
A61K 45/06
C12N 15/11
US Classification:
514 86, 514 88, 514274, 514309
Abstract:
A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

Andrographolide Derivatives To Treat Viral Infections

View page
US Patent:
8445533, May 21, 2013
Filed:
Nov 8, 2005
Appl. No.:
11/269942
Inventors:
Rui Hai Liu - Ithaca NY, US
James R. Jacob - Cortland NY, US
Bud Tennant - Ithaca NY, US
Assignee:
Cornell Research Foundation, Inc. - Ithaca NY
International Classification:
A61K 31/34
US Classification:
514473
Abstract:
The present invention provides a methods and compositions for treating a host afflicted with a viral infection, particularly a Flaviviridae infection, including hepatitis C infection, comprising administering an effective antiviral amount of a derivative of andrographolide alone or in combination or alternation with another antiviral compound.

Method Of Treating Hepatitis Delta Virus Infection

View page
US Patent:
20020160980, Oct 31, 2002
Filed:
Mar 29, 2001
Appl. No.:
09/821278
Inventors:
John Casey - Potomac MD, US
Brent Korba - Laurel MD, US
Paul Cote - New Market MD, US
John Gerin - Bethesda MD, US
Bud Tennant - Ithaca NY, US
Chung Chu - Athens GA, US
International Classification:
C07H019/067
C07H019/073
C07H019/06
C07H019/04
A61K031/7072
US Classification:
514/050000, 514/051000, 536/028550, 536/026140
Abstract:
A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

Flavivirus Associated With Theiler's Disease

View page
US Patent:
20150292042, Oct 15, 2015
Filed:
Oct 31, 2013
Appl. No.:
14/439238
Inventors:
Sanjay CHANDRIANI - Emeryville CA, US
Peter SKEWES-COX - Emeryville CA, US
Thomas DIVERS - Ithaca NY, US
Bud TENNANT - Ithaca NY, US
Amy KISTLER - Emeryville CA, US
- Basel, CH
Assignee:
Novartis Tiergesundheit AG - Basel
International Classification:
C12Q 1/70
Abstract:
This disclosure relates to Theiler's disease-associated virus (“TDAV”), reagents relating thereto, and methods for detecting, using, and/or treating diseases associated with TDAV.
Bud C Tennant from Ithaca, NYDeceased Get Report